InvestWiserEnorama Pharma AB
ERMA · Nasdaq Stockholm · Healthcare
0.67SEK
+2.8%last day
Price as of 1 October 2026
Performance
1 month
−4.3%
1 year
−73.2%
3 years, per year
−43.8%
5 years, per year
−52.7%
Largest fall, 3 years
−97.3%
Below the peak now
−99.6%
Volatility, 1 year
292.7%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
−0.4
Dividend yield
0.0%
Return on equity
−118.3%
Net margin
−112.5%
Market value
5 m USD
Quality, value and trend
Where Enorama Pharma stands against every Nordic stock today. 100 is best.
1
The price measured against earnings, assets and cash flow. Better than 1% of Nordic stocks.
72
The price development over the past year. Better than 72% of Nordic stocks.
About Enorama Pharma
Enorama Pharma AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 4 employees.
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is based in Stockholm, Sweden.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis